These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3274430)

  • 1. Cyclosporine nephrotoxicity and cyclosporine--digoxin interaction prior to heart transplantation.
    Dorian P; Cardella C; Strauss M; David T; East S; Ogilvie R
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1825-7. PubMed ID: 3274430
    [No Abstract]   [Full Text] [Related]  

  • 2. Determinants of cyclosporine nephrotoxicity following cardiac transplantation.
    Martin M; Packham D; Kingswood C; Cairns H; Khaghani A; Thompson D; Yacoub M
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2516-7. PubMed ID: 3274553
    [No Abstract]   [Full Text] [Related]  

  • 3. Results of "immunoconversion" from cyclosporine to azathioprine in heart transplant recipients with progressive nephrotoxicity.
    Hunt SA; Stinson EB; Oyer PE; Billingham ME; Gamberg P; Miller J; Schroeder JS; Baldwin JC; Shumway NE
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2522-4. PubMed ID: 3274554
    [No Abstract]   [Full Text] [Related]  

  • 4. Digoxin-cyclosporine interaction: severe digitalis toxicity after cyclosporine treatment.
    Dorian P; Strauss M; Cardella C; David T; East S; Ogilvie R
    Clin Invest Med; 1988 Apr; 11(2):108-12. PubMed ID: 3396255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine-associated nephrotoxicity is not intractable.
    Loertscher R
    Transplant Proc; 1987 Aug; 19(4):3486-9. PubMed ID: 3303520
    [No Abstract]   [Full Text] [Related]  

  • 6. What is cyclosporine nephrotoxicity?
    Myers BD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1430-2. PubMed ID: 2652460
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclosporine kinetics in pediatric patients with congestive heart failure.
    Burckart GJ; Fricker FJ; Venkataramanan R; Ptachcinski RJ; Hardesty RL; Trento A; Howrie DL; Griffith BP
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1528-9. PubMed ID: 3274373
    [No Abstract]   [Full Text] [Related]  

  • 8. Avoidance of perioperative renal toxicity by a modified immunosuppression protocol.
    Kormos RL; Trento A; Hardesty RL; Griffith BP; Thompson M; Bahnson HT
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2525-6. PubMed ID: 3274555
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine nephropathy after heart and heart-lung transplantation.
    Goldstein J; Thoua Y; Wellens F; Leclerc JL; Vanherweghem JL; Vereerstraeten P; Primo G; Toussaint C
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():973-81. PubMed ID: 3921960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of cyclosporine and ketoconazole without nephrotoxicity in two heart transplant recipients.
    Schroeder TJ; Melvin DB; Clardy CW; Wadhwa NK; Myre SA; Reising JM; Wolf RK; Collins JA; Pesce AJ; First MR
    J Heart Transplant; 1987; 6(2):84-9. PubMed ID: 3305834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming early cyclosporine nephrotoxicity after liver transplantation.
    Burdick JF; Colombani PM; Pitt HA; Perler BA; Merritt WT; Crandall BC; Mitchell MC; Herlong HF; Williams GM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2236-7. PubMed ID: 2652724
    [No Abstract]   [Full Text] [Related]  

  • 13. Is cyclosporine's nephrotoxicity related to its immunosuppressive effectiveness?
    Hakim M; White DJ; Cory-Pearce R; English TA; Wallwork J
    J Heart Transplant; 1985 Feb; 4(2):217-9. PubMed ID: 3916489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of toxic side effects of cyclosporine in heart transplantation.
    Schüler S; Warnecke H; Hetzer R
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2518-21. PubMed ID: 3547936
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of donor age and sex on cyclosporine associated nephrotoxicity.
    Iguro T; Okazaki H; Sato T; Jimbo M; Oguma S
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1554-5. PubMed ID: 2652504
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute renal failure after heart transplantation and cyclosporine therapy.
    McGiffin DC; Kirklin JK; Naftel DC
    J Heart Transplant; 1985; 4(4):396-9. PubMed ID: 3916513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline biopsies define cyclosporine nephrotoxicity.
    Belnap LP; Hammond EH; Yowell R; Richards KF; Rees WV; Stevens LE
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1485. PubMed ID: 2652476
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclosporine in cardiac transplantation.
    Devineni R; McKenzie N; Keown P; Kostuk W; Stiller C; Silver M
    Can J Surg; 1984 May; 27(3):252-4. PubMed ID: 6232993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphology of cyclosporine nephrotoxicity in human heart transplant recipients.
    Chomette G; Auriol M; Beaufils H; Rottemburg J; Cabrol C
    J Heart Transplant; 1986; 5(4):273-8. PubMed ID: 3305818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion from cyclosporine to azathioprine in heart transplant recipients.
    Stevens L; Halbrook H; Berron K; Spears C; Hormuth D
    J Heart Transplant; 1988; 7(2):119-22. PubMed ID: 3284982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.